GA
IBB icon

GFS Advisors’s iShares Biotechnology ETF IBB Stock Holding History

GFS Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,959
Closed -$251K – 148
2025
Q1 		$251K Sell
1,959
-300
-13% -$40.7K 0.05% 111
2024
Q4 		$299K Buy
2,259
+585
+35% +$82.2K 0.05% 132
2024
Q3 		$244K Sell
1,674
-1,904
-53% -$275K 0.05% 104
2024
Q2 		$230K Buy
3,578
+1,904
+114% +$254K 0.04% 139
2024
Q1 		$230K Buy
+1,674
New +$229K 0.04% 132
2022
Q1 		– Sell
-1,625
Closed -$248K – 166
2021
Q4 		$248K Buy
1,625
+100
+7% +$15.5K 0.04% 159
2021
Q3 		$247K Buy
+1,525
New +$257K 0.05% 154

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

GFS Advisors's IBB Position: Q2 2025 in Review

GFS Advisors sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 1,959 shares — an estimated $251K sold.

GFS Advisors first reported a position in IBB in Q3 2021 and held it in 7 quarters. The position peaked at $299K in Q4 2024. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.

  • GFS Advisors reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
  • GFS Advisors sold 1,959 iShares Biotechnology ETF shares in Q2 2025, an estimated $251K.
  • GFS Advisors first reported a position in iShares Biotechnology ETF in Q3 2021 and held it in 7 quarters.
  • GFS Advisors's iShares Biotechnology ETF position peaked at $299K in Q4 2024.
  • 797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.

Based on GFS Advisors's 13F filing for Q2 2025, filed 25 Jul 2025.